The Spectre of SARS-CoV-2 in the Ambient Urban Natural Water in Ahmedabad and Guwahati: A Tale of Two Cities

Abstract

COVID-19 positive patients can egest live SARS-CoV-2 virus through faecal matter and urine, raising concerns about viral transmission through faecal-oral route and/or contaminated aerosolized water. These worries are heightened in many low and middle income nations, where raw sewage is often dumped into surface waterways and open defecation betide. In this manuscript we attempt to discern the presence of SARS-CoV-2 genetic material (ORF-1ab, N and S genes) in two urban cities of India viz., Ahmedabad, in western India with ∼12 WWTPs and Guwahati, in north-east of the country with no such plants. 25.8% and 20% of the surface water samples had detectable SARS-CoV-2 RNA load in Ahmedabad and Guwahati. N-gene>S-gene>ORF-1ab-gene were readily detected in surface water of Ahmedabad, whereas, no such significant trend was found in the case of Guwahati. The high concentration of gene (ORF-1ab – 800 copies/L for Sabarmati river, Ahmedabad and S-gene – 565 copies/L for Bharalu urban river, Guwahati) found in natural waters indicates low sanitation and have various health and ecological consequences that should be investigated further.

• Download figure
• Open in new tab

Highlights

1. Natural urban waters show the presence of SARS-CoV-2 RNA.

2. Lake water receiving runoff containing SARS-CoV-2 genes reflected positive sign early

3. Viral RNA in surface water reflects inadequate sanitation and wastewater management.

4. Residence time and transmission owing to viral RNA in natural waters needs further research.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

UNICEF, INDIA

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

It is not required.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes